<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: : <z:hpo ids='HP_0001919'>Acute kidney injury</z:hpo> (AKIis a common complication in the treatment of patients with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) or high-risk <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (HR-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), but, to the authors' knowledge, its clinical relevance has not been detailed to date </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of the current study was to identify the incidence, predictors, and outcome for AKI in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and HR-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: : Data were analyzed from 537 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or HR-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> undergoing induction chemotherapy from 1999 to 2007 </plain></SENT>
<SENT sid="3" pm="."><plain>Predictors for AKI were identified by logistic regression </plain></SENT>
<SENT sid="4" pm="."><plain>Eight-week mortality of patients was estimated by the Kaplan-Meier method stratified by the RIFLE criteria, a novel multilevel classification system for AKI based on the percent rise in serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> from baseline (Risk, &gt;50%; Injury, &gt;100%; and Failure, &gt;200% or requiring dialysis) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: : A total of 187 patients (36%) developed AKI </plain></SENT>
<SENT sid="6" pm="."><plain>Significant independent risk factors for AKI included the following: age &gt;/=55 years (odds ratio [OR], 1.8), mechanical ventilation (OR, 16), use of <z:chebi fb="0" ids="28001">vancomycin</z:chebi> (OR, 2.3), <z:chebi fb="40" ids="35498">diuretics</z:chebi> (OR, 3.0), <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> <z:chebi fb="23" ids="18059">lipid</z:chebi> formulation (OR, 2.7), vasopressors (OR, 4.9), <z:hpo ids='HP_0001882'>leukopenia</z:hpo> (OR, 1.9), <z:hpo ids='HP_0003073'>hypoalbuminemia</z:hpo> (OR, 1.4), and use of non-fludarabine-based chemotherapy (OR, 2.7) </plain></SENT>
<SENT sid="7" pm="."><plain>The 8-week mortality rates were 3.8%, 13.6%, 19.6%, and 61.7% for the non-RIFLE, Risk, Injury, and Failure categories, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Patients requiring dialysis (8%) had a median survival of 33 days </plain></SENT>
<SENT sid="9" pm="."><plain>Survival of patients who achieved complete remission was favorable, regardless of degree of AKI </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: : The RIFLE classification for AKI appears to have prognostic utility in predicting mortality in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or HR-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Relatively mild elevations in <z:chebi fb="0" ids="16737">creatinine</z:chebi> are associated with higher mortality </plain></SENT>
<SENT sid="12" pm="."><plain>Strategies to avoid nephrotoxic drugs or <z:e sem="disease" ids="C0546817" disease_type="Disease or Syndrome" abbrv="">fluid overload</z:e> may be of benefit </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 2010 </plain></SENT>
<SENT sid="14" pm="."><plain>(c) 2010 American <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Society </plain></SENT>
</text></document>